Business Context and Reporting Period
This Form 8-K reports on the results of the 2019 Annual Meeting of Shareholders for Arvinas, Inc., held on May 23, 2019. The company is an emerging growth company incorporated in Delaware with its principal executive offices in New Haven, Connecticut. Its common stock trades on The Nasdaq Stock Market LLC under the symbol ARVN.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and shareholder voting results rather than financial performance data.
Material Changes and Voting Results
Shareholders voted on two primary proposals at the annual meeting:
- Election of Directors: Three nominees were elected as Class I directors for terms expiring at the 2022 annual meeting.
- John Houston, Ph.D.: 26,055,101 votes For; 402,241 Withheld; 1,057,300 Broker Non-Votes.
- Jakob Loven, Ph.D.: 25,544,085 votes For; 913,257 Withheld; 1,057,300 Broker Non-Votes.
- Kush Parmar, M.D., Ph.D.: 25,975,779 votes For; 481,563 Withheld; 1,057,300 Broker Non-Votes.
- Ratification of Auditors: The appointment of Deloitte and Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019, was ratified.
- For: 27,493,155
- Against: 12,886
- Abstain: 8,601
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Confirmation that the three new directors (Houston, Loven, Parmar) have accepted their roles and will serve until the 2022 annual meeting.
- Verification that Deloitte and Touche LLP has formally accepted the appointment as the independent auditor for the 2019 fiscal year.
- Review of the company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K contains no financial data.